Bank of New York Mellon
IGMS

Bank of New York Mellon’s IGM Biosciences IGMS Stock Holding History

Bank of New York Mellon’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-44,123
Closed -$50.7K – 4198
2025
Q1 		$50.7K Sell
44,123
-3,374
-7% -$6.28K ﹤0.01% 4053
2024
Q4 		$290K Buy
47,497
+1,154
+2% +$13.7K ﹤0.01% 3800
2024
Q3 		$767K Sell
46,343
-7,637
-14% -$83.7K ﹤0.01% 3282
2024
Q2 		$371K Buy
53,980
+4,427
+9% +$37.9K ﹤0.01% 3718
2024
Q1 		$478K Sell
49,553
-2,444
-5% -$28.3K ﹤0.01% 3550
2023
Q4 		$432K Sell
51,997
-71
-0.1% -$412 ﹤0.01% 3631
2023
Q3 		$435K Sell
52,068
-20,120
-28% -$171K ﹤0.01% 3619
2023
Q2 		$666K Buy
72,188
+6,152
+9% +$68.9K ﹤0.01% 3441
2023
Q1 		$907K Sell
66,036
-1,096
-2% -$22.7K ﹤0.01% 3178
2022
Q4 		$1.14M Buy
67,132
+787
+1% +$15.7K ﹤0.01% 3131
2022
Q3 		$1.51M Buy
66,345
+32,231
+94% +$651K ﹤0.01% 3005
2022
Q2 		$616K Buy
34,114
+7,067
+26% +$126K ﹤0.01% 3461
2022
Q1 		$723K Buy
27,047
+728
+3% +$13.6K ﹤0.01% 3503
2021
Q4 		$772K Sell
26,319
-3,193
-11% -$159K ﹤0.01% 3537
2021
Q3 		$1.94M Sell
29,512
-138
-0.5% -$10.6K ﹤0.01% 2991
2021
Q2 		$2.47M Sell
29,650
-3,442
-10% -$255K ﹤0.01% 2859
2021
Q1 		$2.54M Buy
33,092
+95
+0.3% +$8.65K ﹤0.01% 2786
2020
Q4 		$2.91M Sell
32,997
-2,697
-8% -$190K ﹤0.01% 2625
2020
Q3 		$2.63M Sell
35,694
-79
-0.2% -$4.68K ﹤0.01% 2516
2020
Q2 		$2.61M Buy
35,773
+17,082
+91% +$1.04M ﹤0.01% 2524
2020
Q1 		$1.05M Buy
18,691
+3,080
+20% +$135K ﹤0.01% 2943
2019
Q4 		$595K Buy
+15,611
New +$392K ﹤0.01% 3502

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bank of New York Mellon's IGMS Position: Q2 2025 in Review

Bank of New York Mellon sold out of IGM Biosciences (IGMS) in Q2 2025, closing a stake of 44,123 shares — an estimated $50.7K sold.

Bank of New York Mellon first reported a position in IGMS in Q4 2019 and held it in 22 quarters. The position peaked at $2.91M in Q4 2020. 66 funds tracked by Wall St. Rank hold IGMS as of Q2 2025.

  • Bank of New York Mellon reported no remaining IGM Biosciences position as of Q2 2025 after selling out during the quarter.
  • Bank of New York Mellon sold 44,123 IGM Biosciences shares in Q2 2025, an estimated $50.7K.
  • Bank of New York Mellon first reported a position in IGM Biosciences in Q4 2019 and held it in 22 quarters.
  • Bank of New York Mellon's IGM Biosciences position peaked at $2.91M in Q4 2020.
  • 66 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2025.

Based on Bank of New York Mellon's 13F filing for Q2 2025, filed 5 Aug 2025.